CNN TürkKPSS ORTAÖĞRETİM LİSE SINAV SONUÇLARI SORGULAMA EKRANI: 2026 KPSS Ortaöğretim sonuçları açıklandı mı?PunchFG hails Adamu’s confirmation as CAF secretary-general한겨레고단한 삶 품어주던 자리, 그 온기만큼은 오래 남으리InquirerManila North Cemetery logs over 1.3 million visitors on All Saints’ DayZDF heuteEntdecken Sie das ZDF-NachrichtenstudioSouth China Morning PostHas Hong Kong’s IPO boom hit a wall – or is a year-end rush still to come?The Hollywood ReporterBook to Scream: How Universal Orlando’s Halloween Event Embraced Horror’s Literary Roots for 35 YearsCumhuriyetYüksek Yerilim Hattı - 2 Kasım 2026The Sydney Morning HeraldBar GabiSportstarIndia A vs New Zealand A LIVE Score, 2nd unofficial Test Day 3: NZ A crosses 300-run mark; Siraj picks up four wickets매일경제전력부족 공포 ‘체르노빌 트라우마’ 넘어섰다…원전건설 40년만 최다Lenta.ruРоссиянам назвали условия для получения сразу двух пенсий
The Daily Newsstand · Free, Always
Monday, November 2, 2026

東亜ST、胃炎薬「スティレンQ錠」承認…1日1回服用

Translate

東亜STが急性・慢性胃炎治療薬「スティレンQ錠」の韓国内品目許可を取得した。既存のスティレン錠と主成分は同じだが、服用回数を1日3回から1回に減らしたのが特徴だ。食品医薬品安全処は先月30日、スティレンQ錠を許可した。同社は4月16日に品目許可を申請し、約6カ月で許可を取得した。スティレンQ錠は艾葉(ヨモギ)から抽出した成分である「艾葉95%エタノール

Read the full article on 조선일보 →

KioskNews shows the publisher’s own headline, image, and summary — the full article always lives on their site, not ours.